首页> 外文期刊>Archivum Immunologiae et Therapiae Experimentalis >Serodiagnostic Efficacy of Mycobacterium tuberculosis 30/32-kDa Mycolyl Transferase Complex, ESAT-6, and CFP-10 in Patients with Active Tuberculosis
【24h】

Serodiagnostic Efficacy of Mycobacterium tuberculosis 30/32-kDa Mycolyl Transferase Complex, ESAT-6, and CFP-10 in Patients with Active Tuberculosis

机译:结核分枝杆菌30 / 32-kDa霉菌转移酶复合物,ESAT-6和CFP-10在活动性肺结核患者中的血清学诊断功效

获取原文
获取原文并翻译 | 示例
           

摘要

Elimination of tuberculosis (TB) largely depends upon definitive rapid diagnosis and treatment. Widely used diagnostic tests do not qualify for use in a developing country due to lack of either desired accuracy or their cost. In the present study an enzyme-linked immunosorbent assay was used to evaluate the diagnostic potential of an immuno-dominant 30/32-kDa mycolyl transferase complex (Ag85 complex) and Mycobacterium tuberculosis-specific proteins (ESAT-6 and CFP-10) of the RD1 region. Higher sensitivity (84.1%) with Ag85 complex was observed compared with ESAT-6 (64.9%) and CFP-10 (66%), with almost similar specificity (Ag85: 85.2%, ESAT-6: 88.9%, CFP-10: 85.2%), whereas the individual components of Ag85 complex, i.e. Ag85A, Ag85B, and Ag85C, showed sensitivities of 44.6, 34, and 80.9% and specificities of 55.6, 74.1, and 40.7% respectively. A cocktail of Ag85 complex, ESAT-6, CFP-10, Ag85A, Ag85B, and Ag85C antigens also could not help in increasing either sensitivity (51.1%) or specificity (85.2%). Furthermore, immunoblot analysis using clinical isolates as well as a standard strain (H37Rv) of M. tuberculosis also showed strong reactivity of sera from TB patients to Ag85 complex and, to a lesser extent, also to ESAT-6. To conclude, use of Ag85 complex along with ESAT-6 and CFP-10 seems to be promising in minimizing the heterogeneous sero-responses of adult TB cases. Keywords Secretory proteins - 30/32-kDa Mycolyl transferase complex - ESAT-6/CFP-10 - Serodiagnosis - Tuberculosis
机译:消除结核病(TB)很大程度上取决于最终的快速诊断和治疗。由于缺乏所需的准确性或成本,广泛使用的诊断测试不符合在发展中国家使用的条件。在本研究中,使用酶联免疫吸附测定法评估了以免疫为主的30 / 32-kDa霉菌转移酶复合物(Ag85复合物)和结核分枝杆菌特异性蛋白(ESAT-6和CFP-10)的诊断潜力。 RD1地区。与ESAT-6(64.9%)和CFP-10(66%)相比,Ag85复合物具有更高的敏感性(84.1%),特异性几乎相似(Ag85:85.2%,ESAT-6:88.9%,CFP-10: 85.2%),而Ag85复合物的各个成分,即Ag85A,Ag85B和Ag85C,分别显示出44.6%,34%和80.9%的敏感性和55.6%,74.1%和40.7%的特异性。 Ag85复合物,ESAT-6,CFP-10,Ag85A,Ag85B和Ag85C抗原的混合物也不能帮助提高敏感性(51.1%)或特异性(85.2%)。此外,使用临床分离株以及结核分枝杆菌的标准菌株(H37Rv)进行的免疫印迹分析还显示,来自结核病患者的血清对Ag85复合物具有较强的反应性,在较小程度上也对ESAT-6具有反应性。总而言之,将Ag85复合物与ESAT-6和CFP-10结合使用似乎有望将成人结核病患者的异种血清反应降至最低。关键词分泌蛋白-30 / 32-kDa霉菌转移酶复合物-ESAT-6 / CFP-10-血清诊断-结核

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号